EFM
KYMR icon

E Fund Management’s Kymera Therapeutics KYMR Stock Holding History

E Fund Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597K Sell
5,209
-21,022
-80% -$1.81M 0.01% 233
2026
Q1 		$2.18M Buy
+26,231
New +$2.08M 0.06% 141
2025
Q2 		– Sell
-71,863
Closed -$1.97M – 414
2025
Q1 		$1.97M Buy
71,863
+4,795
+7% +$175K 0.09% 116
2024
Q4 		$2.7M Buy
67,068
+12,776
+24% +$577K 0.14% 92
2024
Q3 		$2.57M Buy
54,292
+5,346
+11% +$236K 0.13% 79
2024
Q2 		$1.46M Buy
48,946
+38,981
+391% +$1.35M 0.08% 98
2024
Q1 		$401K Buy
+9,965
New +$357K 0.02% 220
2023
Q3 		– Sell
-11,530
Closed -$265K – 307
2023
Q2 		$265K Sell
11,530
-340
-3% -$9.74K 0.02% 231
2023
Q1 		$352K Buy
11,870
+578
+5% +$18.6K 0.03% 205
2022
Q4 		$282K Sell
11,292
-1,050
-9% -$28K 0.02% 241
2022
Q3 		$269K Sell
12,342
-4,901
-28% -$129K 0.03% 250
2022
Q2 		$340K Buy
17,243
+11,015
+177% +$257K 0.03% 215
2022
Q1 		$264K Buy
6,228
+3,078
+98% +$130K 0.01% 242
2021
Q4 		$200K Buy
+3,150
New +$183K 0.01% 262

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

E Fund Management's KYMR Position: Q2 2026 in Review

E Fund Management reduced its Kymera Therapeutics (KYMR) stake by 80% in Q2 2026, selling an estimated $1.81M and leaving 5,209 shares worth $597K. The position accounts for 0.01% of the portfolio, ranked #233.

E Fund Management first reported a position in KYMR in Q4 2021 and has held it in 14 quarters since. The position peaked at $2.7M in Q4 2024. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • E Fund Management held 5,209 shares of Kymera Therapeutics worth $597K as of Q2 2026.
  • E Fund Management sold 21,022 Kymera Therapeutics shares in Q2 2026, an estimated $1.81M.
  • Kymera Therapeutics made up 0.01% of E Fund Management's portfolio in Q2 2026, its #233 holding.
  • E Fund Management first reported a position in Kymera Therapeutics in Q4 2021 and has held it in 14 quarters since.
  • E Fund Management's Kymera Therapeutics position peaked at $2.7M in Q4 2024.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.